Literature DB >> 7905383

Characterization of cytochrome P-450 2B6 in human liver microsomes.

M Mimura1, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich, T Shimada.   

Abstract

A cytochrome P-450 (P-450) enzyme of the CYP2B subfamily was partially purified from human liver microsomes and characterized with respect to immunochemical properties, N-terminal amino acid sequence, and catalytic activities toward typical P-450 substrates. P-450 enzymes were monitored in chromatographic fractions by immunoblotting analysis using antibodies raised against a monkey P-450 2B, as well as several purified human P-450 enzymes. The final P-450 2B preparation thus obtained was contaminated with P-450 3A4, but an N-terminal amino acid sequence matching the sequence predicted from the CYP2B6 cDNA was obtained. The apparent M(r) of this protein was 48 kDa, and the migration on sodium dodecyl sulfate-polyacrylamide gel electrophoresis was the same as that of the P-450 2B6 protein expressed in a human lymphoblast cell line. Immunoblotting analysis of 50 human liver samples revealed that the protein band considered to be P-450 2B6 was detected in only 12 samples, with four of these having relatively high levels. Several activities toward typical P-450 substrates were determined in a reconstituted monooxygenase system containing partially purified P-450 2B6 and compared with those obtained using a highly purified preparation of P-450 3A4 enzyme; we found that most of the activities were similar in these preparations, except that the partially purified P-450 2B6 showed high rates of activation of the mutagens 6-aminochrysene and 3-methoxy-4-aminoazobenzene to genotoxic metabolites in Salmonella typhimurium NM2009 strain.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7905383

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo.

Authors:  Zhihua Liu; Lei Li; Hong Wu; Jing Hu; Jun Ma; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2014-11-19       Impact factor: 3.922

3.  Methadone Disposition: Implementing Lessons Learned.

Authors:  Evan D Kharasch; David J Greenblatt
Journal:  J Clin Pharmacol       Date:  2019-05-01       Impact factor: 3.126

4.  Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours.

Authors:  K T Kivistö; E U Griese; P Fritz; A Linder; J Hakkola; H Raunio; P Beaune; H K Kroemer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

5.  Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys.

Authors:  Shotaro Uehara; Norie Murayama; Yasuharu Nakanishi; Darryl C Zeldin; Hiroshi Yamazaki; Yasuhiro Uno
Journal:  J Pharmacol Exp Ther       Date:  2011-08-17       Impact factor: 4.030

Review 6.  The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.

Authors:  K T Kivistö; H K Kroemer; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

7.  New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis.

Authors:  L E Korhonen; M Turpeinen; M Rahnasto; C Wittekindt; A Poso; O Pelkonen; H Raunio; R O Juvonen
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

Review 8.  CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

Authors:  Hongbing Wang; Leslie M Tompkins
Journal:  Curr Drug Metab       Date:  2008-09       Impact factor: 3.731

9.  Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.

Authors:  Stanislav Micuda; Lucie Mundlova; Eva Anzenbacherova; Pavel Anzenbacher; Jaroslav Chladek; Leos Fuksa; Jirina Martinkova
Journal:  Eur J Clin Pharmacol       Date:  2004-09-16       Impact factor: 2.953

10.  Developmental Expression of CYP2B6: A Comprehensive Analysis of mRNA Expression, Protein Content and Bupropion Hydroxylase Activity and the Impact of Genetic Variation.

Authors:  Robin E Pearce; Roger Gaedigk; Greyson P Twist; Hongying Dai; Amanda K Riffel; J Steven Leeder; Andrea Gaedigk
Journal:  Drug Metab Dispos       Date:  2015-11-25       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.